优化安全阿片类药物处方:骨科手术中丁丙诺啡管理的范式转变
文章更新了骨科医生对丁丙诺啡作为镇痛药的认识,并分享循证实践指南。对于因阿片类药物使用障碍或慢性疼痛而使用丁丙诺啡的患者,更新建议是围手术期继续其居家剂量,并联系开具处方的医生。继续丁丙诺啡应伴随多模式镇痛,包括术前讨论、区域麻醉、 standing 对乙酰氨基酚、非甾体抗炎药、加巴喷丁类药物、冷疗、抬高和早期活动;透皮丁丙诺啡正成为急性围手术期疼痛管理的优良选择。
要点
- 因阿片类药物使用障碍或慢性疼痛使用丁丙诺啡的患者,围手术期继续居家剂量。
- 继续丁丙诺啡应伴随多模式镇痛,包括区域麻醉、对乙酰氨基酚、非甾体抗炎药等。
- 透皮丁丙诺啡单贴可提供长达1周的稳定镇痛,有助于提高依从性。
核心结论
- 对于因阿片类药物使用障碍或慢性疼痛而使用丁丙诺啡的患者,更新建议是围手术期继续其居家剂量的丁丙诺啡。
- 透皮丁丙诺啡正成为择期和非择期骨科患者急性围手术期疼痛管理的优良选择。
研究设计与样本
- 本文为叙述性综述,旨在更新骨科医生对丁丙诺啡作为镇痛药的认识,并分享循证实践指南。
主要发现
- 单贴透皮丁丙诺啡可在术后期间提供长达1周的稳定镇痛药物剂量。
- 贴剂给药方式有助于对抗患者不依从,并最终提供更好的整体疼痛控制。
- 未来,透皮丁丙诺啡贴剂几乎可应用于所有骨折手术、脊柱手术、全关节置换术、带骨钻孔的韧带重建等。
关键数值与推荐
- 对于因阿片类药物使用障碍或慢性疼痛使用丁丙诺啡的患者,更新建议是围手术期继续其居家剂量。
- 应联系患者的丁丙诺啡处方医生并告知任何即将进行的手术。
- 继续丁丙诺啡应伴随多模式镇痛,包括术前讨论疼痛和疼痛控制预期、区域麻醉、 standing 对乙酰氨基酚、尽可能使用非甾体抗炎药、65岁以下患者夜间使用加巴喷丁类药物、冷疗、抬高和早期活动。
- 患者还可处方短效、即释阿片类药物用于爆发痛。
临床怎么用
- 骨科医生应联系患者的丁丙诺啡处方医生并告知任何即将进行的手术。
- 继续丁丙诺啡应伴随多模式镇痛,包括术前讨论疼痛和疼痛控制预期、区域麻醉、 standing 对乙酰氨基酚、尽可能使用非甾体抗炎药、65岁以下患者夜间使用加巴喷丁类药物、冷疗、抬高和早期活动。
- 患者可处方短效、即释阿片类药物用于爆发痛。
- 透皮丁丙诺啡正成为择期和非择期骨科患者急性围手术期疼痛管理的优良选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The worsening opioid epidemic in the United States, exacerbated by the COVID-19 pandemic, necessitates innovative approaches to pain management. Buprenorphine, a long-acting opioid, has gained popularity due to its safety profile and accessibility. Orthopaedic surgeons, encountering an increasing number of patients on buprenorphine, face challenges in perioperative management. This article will update orthopaedic surgeons on new developments in the understanding of buprenorphine as a pain reliever and share evidence-based practice guidelines for buprenorphine management. For patients on buprenorphine for opioid use disorder or chronic pain, the updated recommendation is to continue their home dose of buprenorphine through the perioperative period. The patient's buprenorphine prescriber should be contacted and notified of any impending surgery. The continuation of buprenorphine should be accompanied by a multimodal approach to analgesia, including a preoperative discussion about expectations of pain and pain control, regional anesthesia, standing acetaminophen, Nonsteroidal anti-inflammatory drugs when possible, gabapentinoids at night for patients under 65 years, cryotherapy, elevation, and early mobilization. Patients can also be prescribed short-acting, immediate-release opioids for breakthrough pain. Transdermal buprenorphine is emerging as an excellent option for the management of acute perioperative pain in both elective and nonelective orthopaedic patients. A single patch can provide a steady dose of pain medication for up to 1 week during the postoperative period. A patch delivery method can help combat patient nonadherence and ultimately provide better overall pain control. In the future, transdermal buprenorphine patches could be applied in virtually all fracture surgery, spinal surgery, total joint arthroplasty, ligament reconstructions with bony drilling, etc. As the stigma surrounding buprenorphine decreases, further opportunities for perioperative use may develop.
引用
- Morrissey PJ, Quinn M, Mikolasko B, et al. Optimizing Safe Opioid Prescribing: A Paradigm Shift in Buprenorphine Management for Orthopaedic Surgery. J Arthroplasty. 2024. PMID: 38914144. doi:10.1016/j.arth.2024.06.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。